| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10-3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10-3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10-3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10-3/Sv이다. |
||
| GM-CSF | Granulocyte-Macrophage Colony Stimulating Factor |
|---|---|
| G-CSF | granulocyte colony-stimulating factor |
| GCSFR | granulocyte colony-stimulating factor receptor |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| GPE | guinea pig embryo; granulocyte colony-stimulating factor promoter element |
| rGM-CSF | Recombinant granulocyte-macrophage colony-stimulating factor |
|---|---|
| rHuG-CSF | Recombinant human granulocyte colony stimulating factor |
| rhG-CSF | Recombinant human granulocyte colony stimulating factor |
| rG-CSF | Recombinant human granulocyte colony-stimulating factor |
| rHu GM-CSF | Recombinant human granulocyte-macrophage colony-stimulating factor |
| immature granulocyte | An immature neutrophil, except that it may be neutrophilic, acidophilic, or basophilic in character. (05 Mar 2000) |
|---|---|
| recombinant | <molecular biology> A cell or an individual with a new combination of genes not found together in either parent, usually applied to linked genes. (18 Nov 1997) |
| recombinant clone | <molecular biology> Clones containing recombinant DNA molecules. See: recombinant DNA technologies. (14 Oct 1997) |
| recombinant clones | Clones containing recombinant DNA molecules. (12 Dec 1998) |
| recombinant DNA | <molecular biology> Spliced DNA formed from two or more different sources that have been cleaved by restriction enzymes and joined by ligases. (18 Nov 1997) |
| recombinant DNA molecules | A combination of DNA molecules of different origin that are joined using recombinant DNA technology. (12 Dec 1998) |
| recombinant DNA technologies | Procedures used to join together DNA segments in a cell-free system (an environment outside a cell ororganism). Under appropriate conditions, a recombinant DNA molecule canenter a cell and replicate there, either autonomously or after it hasbecome integrated into a cellular chromosome. (09 Oct 1997) |
| recombinant DNA technology | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| recombinant fusion proteins | Proteins that are the result of genetic engineering. A regulatory part or promoter of one or more genes is combined with a structural gene. The fusion protein is formed after transcription and translation of the fused gene. This type of fusion protein is used in the study of gene regulation or structure-activity relationships. They might also be used clinically as targeted toxins (immunotoxins). (12 Dec 1998) |
| recombinant proteins | Proteins prepared by recombinant DNA technology. (12 Dec 1998) |
| recombinant strain | <molecular biology> A cell or an individual with a new combination of genes not found together in either parent, usually applied to linked genes. (18 Nov 1997) |
| recombinant vector | A vector into which a foreign DNA has been inserted. Synonym: vector. (05 Mar 2000) |
| clones, recombinant | Clones containing recombinant DNA molecules. (12 Dec 1998) |
| molecules, recombinant DNA | A combination of DNA molecules of different origin that are joined using recombinant DNA technology. (12 Dec 1998) |
| somatotropins, recombinant | Somatotropin prepared by recombinant DNA technology. Several different forms have been developed from humans, cows, and pigs. They have been used to help stimulate growth. (12 Dec 1998) |